These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9167795)

  • 1. Citalopram and panic disorder.
    Bertani A; Perna G; Politi E; Bellodi L
    Depress Anxiety; 1996-1997; 4(5):253. PubMed ID: 9167795
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of salbutamol-induced panic disorder with citalopram.
    Rihmer Z
    Eur Neuropsychopharmacol; 1997 Aug; 7(3):241-2. PubMed ID: 9213085
    [No Abstract]   [Full Text] [Related]  

  • 3. Citalopram-induced major depression in a patient with panic disorder - a case report.
    Hofmann P; Conrad R
    Psychiatr Danub; 2012 Mar; 24(1):94-6. PubMed ID: 22447093
    [No Abstract]   [Full Text] [Related]  

  • 4. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
    Seedat S; van Rheede van Oudtshoorn E; Muller JE; Mohr N; Stein DJ
    Int Clin Psychopharmacol; 2003 Sep; 18(5):279-84. PubMed ID: 12920388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of citalopram in panic disorder.
    Wade AG; Lepola U; Koponen HJ; Pedersen V; Pedersen T
    Br J Psychiatry; 1997 Jun; 170():549-53. PubMed ID: 9330022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of SSRIs in panic disorder.
    Sheehan DV; Harnett-Sheehan K
    J Clin Psychiatry; 1996; 57 Suppl 10():51-8; discussion 59-60. PubMed ID: 8917132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.
    Shlik J; Aluoja A; Vasar V; Vasar E; Podar T; Bradwejn J
    J Psychiatry Neurosci; 1997 Nov; 22(5):332-40. PubMed ID: 9401314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram: new indication. No advantage.
    Prescrire Int; 1999 Feb; 8(39):18-9. PubMed ID: 10557570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.
    Herrán A; Ramírez ML; Carrera M; García-Unzueta MT; Sierra-Biddle D; Rodríguez-Cabo B; Ayestarán A; Hoyuela F; Vázquez-Barquero JL
    J Clin Psychopharmacol; 2006 Oct; 26(5):538-40. PubMed ID: 16974205
    [No Abstract]   [Full Text] [Related]  

  • 10. [Citalopram in the treatment of panic disorders and school phobia in children and adolescents].
    Lepola U; Leinonen E; Koponen H
    Duodecim; 1994; 110(1):60-2. PubMed ID: 7555751
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactive case conference. First episode: depression and panic disorder.
    Dunner DL
    CNS Spectr; 2005 Sep; 10(9):696-7. PubMed ID: 16142209
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
    Esler M; Lambert E; Alvarenga M; Socratous F; Richards J; Barton D; Pier C; Brenchley C; Dawood T; Hastings J; Guo L; Haikerwal D; Kaye D; Jennings G; Kalff V; Kelly M; Wiesner G; Lambert G
    Stress; 2007 Aug; 10(3):295-304. PubMed ID: 17613943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram in Treatment of Pregnant Women With Panic Disorder: A Retrospective Study.
    Uguz F
    J Clin Psychopharmacol; 2020; 40(6):615-617. PubMed ID: 32991527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram in the treatment of early-onset panic disorder and school phobia.
    Lepola U; Leinonen E; Koponen H
    Pharmacopsychiatry; 1996 Jan; 29(1):30-2. PubMed ID: 8852532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of electric shock-like sensations on escitalopram discontinuation.
    Prakash O; Dhar V
    J Clin Psychopharmacol; 2008 Jun; 28(3):359-60. PubMed ID: 18480703
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of escitalopram on metabolic parameters in patients with major depressive disorder, generalised anxiety disorder, and panic disorder: a prospective 6-month follow-up study.
    Peh AL; Nieng CH; Ling YH; Kheng TW; Neng TS; Koon OG
    Asian J Psychiatr; 2013 Jun; 6(3):256-7. PubMed ID: 23642988
    [No Abstract]   [Full Text] [Related]  

  • 17. Exacerbation of respiratory symptoms in patients with panic disorder.
    Bouwer CD; Stein DJ; Hawkridge SM
    Am J Psychiatry; 1997 May; 154(5):712-3. PubMed ID: 9137136
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
    Mochcovitch MD; Nardi AE
    Expert Rev Neurother; 2010 Aug; 10(8):1285-93. PubMed ID: 20662754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Citalopram].
    El-Armouche A; Zolk O; Eschenhagen T
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2253-6. PubMed ID: 14574639
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders.
    Humble M; Wistedt B
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():21-39. PubMed ID: 1431019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.